三部曲的药物用于癌症和化疗引起的心力衰竭的共同治疗药物重用
Xin Chen1,2, Xianggang Mu1, Lele Ding3
1State Key Laboratory of Bioreactor Engineering, Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
这项研究引入了一种新的药物重定向策略,以创建保护心脏的双重作用癌症疗法. 在临床前模型中,一种卡维迪醇衍生物 (43) 有效地平衡了抗癌和心脏保护作用.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗在癌症幸存者中引起危及生命的心血管并发症,阻碍治疗的有效性.
- 现有的心脏保护剂不足以应对这些双重挑战.
- 双功能联合治疗剂提供了一个有前途的策略,可以同时增强化疗和减轻心脏事件.
研究的目的:
- 提出和验证一种"药物重用三部曲"战略,用于开发新型双功能药物.
- 确定具有抗癌和心脏保护潜力的重用药物.
- 合成和评估卡维迪醇衍生物,以获得平衡的治疗效果.
主要方法:
- 一种系统的"药物重用三部曲"方法,结合了基于功能,以目标为中心和支架驱动的方法.
- 鉴定卡维迪醇 (CAR) 作为一种心脏保护剂,具有针对肺癌潜在的低缩抑制活性.
- 在临床前模型中合成了44种CAR衍生物,并评估了它们的双重抗癌和心脏保护功效.
主要成果:
- "药物重用三部曲"战略在开发双功能药物的过程中被证明是有效的.
- 卡维迪醇衍生物43显示出显著的双重抗癌和心脏保护性质.
- 衍生品43在已确定的心力衰竭小鼠模型中显示出有效性,有和没有瘤.
结论:
- 拟议的"药物重用三部曲"战略是设计有效的双功能联合治疗剂的实用方法.
- 卡维迪醇衍生物43代表了癌症和心血管治疗联合的有希望的候选人.
- 这项研究验证了一种新的方法来解决癌症治疗中复杂的并发症.
更多相关视频
10:05Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Inotropic Agents
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Heart Failure Drugs: Diuretics
Heart Failure Drugs: β-Blockers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
